News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-12-16 11:3:44 pm Week In Review: SystImmune Out-Licenses Global Rights For ADC To BMS In $8.4B Deal SeekingAlpha
2023-12-12 3:0:0 am Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma GlobeNewswire
2023-12-11 1:5:0 pm Connect Biopharma to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023 GlobeNewswire
2023-11-30 6:45:0 am Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management Newsfile
2023-11-28 6:40:7 am Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year? Zacks
2023-11-21 4:32:14 am Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday InvestorPlace
2023-11-21 3:3:0 am Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China GlobeNewswire
2023-11-21 3:0:0 am Connect Biopharma Announces Positive Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis GlobeNewswire
2023-11-20 1:41:0 pm Connect Biopharma to Announce Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis on November 21, 2023 GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information